Orlova A. M. Anna Markovna, Rybina A. N. Anastasiya Nikolaevna, Medvedeva А. А. Anna Aleksandrovna, Zelchan R. V. Roman Vladimirovich, Bragina O. D. Olga Dmitrievna, Tashireva L. A. Lyubov Aleksandrovna, . . . Chernov V. I. Vladimir Ivanovich. (2025). Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?; Pharmaceutics; Vol. 17, iss. 10. 2025. https://doi.org/10.3390/pharmaceutics17101323
Chicago Style (17th ed.) CitationOrlova A. M. Anna Markovna, et al. Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?; Pharmaceutics; Vol. 17, Iss. 10. 2025, 2025. https://doi.org/10.3390/pharmaceutics17101323.
ציטוט MLAOrlova A. M. Anna Markovna, et al. Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?; Pharmaceutics; Vol. 17, Iss. 10. 2025, 2025. https://doi.org/10.3390/pharmaceutics17101323.